Scale, Landscape, And Rigid Growth Logic Of The Puncture Needle Industry

https://www.medicalexpo.com/medical-manufacturer/puncture-needle-3117.html

As a Class II core precision medical device, puncture needles cover four major tracks: medical diagnosis/treatment, medical aesthetics skincare, pharmaceutical research and development, and veterinary medicine. With rigid demand attributes and broad scenario adaptability, the industry market continues to expand rapidly, becoming a golden track in the segmented field of medical devices. Driven by multiple factors such as population aging, the popularization of minimally invasive medicine, the explosion of light medical aesthetics, and the upgrading of grassroots medical care, the scale of the puncture needle industry is growing steadily, the process of domestic substitution is accelerating, and the industry's development potential is continuously being released.

From the perspective of global market size, the puncture needle industry maintains a steady growth trend. According to industry research data, the global revenue of puncture needles reached USD 2.152 billion in 2025, and is expected to grow to USD 2.291 billion in 2026. The compound annual growth rate (CAGR) from 2026 to 2032 is maintained at 5.98%, and it is estimated that the global market size will exceed USD 3.2 billion by 2032, with continued rigid growth in market demand. Looking at the domestic market, the industry growth rate far exceeds the global average. In 2025, China's puncture needle market size reached RMB 14.86 billion, a year-on-year increase of 9.3%. The CAGR over the past five years exceeded 10%, and it is expected to maintain double-digit high-speed growth in the next five years.

From the perspective of product structure, disposable puncture needles dominate the market, accounting for 78.2% of the overall market share. With advantages such as safety, hygiene, prevention of cross-infection, and high cost-effectiveness, they have become the preferred products for medical institutions and medical aesthetics institutions at all levels. Among subcategories, biopsy puncture needles have the fastest growth rate, with an annual growth rate of 12.5%. Benefiting from the popularization of early cancer screening and the normalization of chronic disease testing, the demand for clinical sampling puncture needles continues to explode. In addition, the demand for subdivided categories such as minimally invasive drug delivery needles, medical aesthetics microneedles, and interventional therapy needles is also rising simultaneously, and the product system continues to improve.

From the perspective of market competition landscape, the domestic puncture needle industry presents a pattern of "domestic monopoly in the mid-to-low end, accelerated breakthroughs in the high-end." Currently, domestic puncture needles have achieved comprehensive substitution in the mid-to-low end market, occupying more than 68% of the market share. With advantages such as high cost-effectiveness, rapid supply, and localized service, they cover primary medical institutions, small and medium-sized medical aesthetics institutions, and ordinary clinical scenarios. In the field of high-end precision puncture needles, such as intelligent navigation puncture needles, high-precision biopsy needles, and special needles for interventional therapy, which previously relied on imports for a long time, domestic enterprises have continued to break through core technologies such as precision machining, material improvement, and accuracy calibration in recent years, accelerating the domestic substitution process of high-end products.

The core driving logic of industry growth is clear and definite. First, the aggravation of population aging drives the rise in the incidence of chronic diseases and tumors, promoting the continuous expansion of demand for clinical puncture sampling and minimally invasive interventional therapy. Second, minimally invasive medicine has become the mainstream of the industry, replacing traditional invasive surgeries and driving the rigid growth of demand for puncture needles. Third, the standardized development of the light medical aesthetics industry and the popularization of microneedle skincare have opened up a brand-new incremental market. Fourth, the standardized upgrading of grassroots medical equipment and the continuous increase in the allocation rate of puncture needles continuously release the potential of the sinking market.

Overall, the puncture needle industry has extremely strong rigid demand attributes, diverse downstream scenarios, and sufficient growth momentum. With continuous technological iteration, acceleration of the domestic substitution process, and continuous expansion of downstream markets, the industry will maintain long-term steady growth in the future, becoming one of the most promising tracks in the segmented field of medical devices.